Richard D. Pilnik is Director of DiaMedica Therapeutics Inc.. Currently has a direct ownership of 278,602 shares of DMAC, which is worth approximately $1.23 Million. The most recent transaction as insider was on Jan 02, 2024, when has been sold 30,357 shares (Voting Common Shares, no par value per share) at a price of $2.8 per share, resulting in proceeds of $84,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 279K
0% 3M change
12.23% 12M change
Total Value Held $1.23 Million

Richard D. Pilnik Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2024
BUY
Grant, award, or other acquisition
$84,999 $2.8 p/Share
30,357 Added 9.83%
278,602 Voting Common Shares, ...
Jun 23 2023
BUY
Open market or private purchase
$149,999 $3.91 p/Share
38,363 Added 13.39%
248,245 Voting Common Shares, ...
Jan 03 2023
BUY
Grant, award, or other acquisition
$84,999 $1.53 p/Share
55,555 Added 20.93%
209,882 Voting Common Shares, ...
Dec 05 2022
BUY
Open market or private purchase
$48,650 $1.39 p/Share
35,000 Added 18.49%
154,327 Voting Common Shares, ...
Jan 03 2022
BUY
Grant, award, or other acquisition
$85,068 $3.58 p/Share
23,762 Added 16.61%
119,327 Voting Common Shares, ...
Aug 16 2021
BUY
Open market or private purchase
$48,750 $3.25 p/Share
15,000 Added 13.57%
95,565 Voting Common Shares, ...
Jan 01 2021
BUY
Grant, award, or other acquisition
$79,987 $8.23 p/Share
9,719 Added 10.76%
80,565 Voting Common Shares, ...
Dec 04 2020
BUY
Open market or private purchase
$53,700 $5.37 p/Share
10,000 Added 12.37%
70,846 Voting Common Shares, ...
RDP

Richard D. Pilnik

Director
Minneapolis, MN

Track Institutional and Insider Activities on DMAC

Follow DiaMedica Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DMAC shares.

Notify only if

Insider Trading

Get notified when an Dia Medica Therapeutics Inc. insider buys or sells DMAC shares.

Notify only if

News

Receive news related to DiaMedica Therapeutics Inc.

Track Activities on DMAC